Katamaran Industries
Katamaran delivers faster drug discovery for cancer therapies by using patient-derived tumoroids, automation, and AI. The platform combines these technologies—tumoroids, automation including robotic processes, and generative AI—to accelerate development and reduce costs for pharma programs. It emphasizes precision medicine and diverse, human-relevant data to broaden access to effective treatments. As a B2B SaaS offering, it serves pharmaceutical companies and research teams seeking scalable oncology and rare-disease solutions.
Katamaran Industries
Katamaran delivers faster drug discovery for cancer therapies by using patient-derived tumoroids, automation, and AI. The platform combines these technologies—tumoroids, automation including robotic processes, and generative AI—to accelerate development and reduce costs for pharma programs. It emphasizes precision medicine and diverse, human-relevant data to broaden access to effective treatments. As a B2B SaaS offering, it serves pharmaceutical companies and research teams seeking scalable oncology and rare-disease solutions.